Geode Capital Management, LLC Amryt Pharma PLC Transaction History

Geode Capital Management, LLC

  • $1.12 Trillion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$6.8 - $8.01 $15,062 - $17,742
2,215 Added 7.41%
32,094 $222,000
Q1 2022

May 13, 2022
SELL
$6.3 - $10.86 $1,568 - $2,704
-249 Reduced 0.83%
29,879 $246,000
Q4 2021

Feb 11, 2022
SELL
$9.44 - $12.24 $500 - $648
-53 Reduced 0.18%
30,128 $325,000
Q3 2021

Nov 12, 2021
BUY
$9.63 - $12.47 $193,938 - $251,133
20,139 Added 200.55%
30,181 $364,000
Q2 2021

Aug 13, 2021
BUY
$10.9 - $14.29 $109,457 - $143,500
10,042 New
10,042 $121,000

Others Institutions Holding AMYT

# of Institutions
5
Shares Held
142K
Call Options Held
0
Put Options Held
0
View Full List

About Amryt Pharma plc

AMYT Quotes by TradingView
  • Ticker AMYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 64,177,000
  • Description
  • Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with ...
More about AMYT
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email